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Purpose: To determine the retinal disease expression in the rare form of Leber congenital amaurosis (LCA) caused by
Lebercilin (LCA5) mutation.
Methods: Two young unrelated LCA patients, ages six years (P1) and 25 years (P2) at last visit, both with the same
homozygous mutation in the LCA5 gene, were evaluated clinically and with noninvasive studies. En face imaging was
performed with near-infrared (NIR) reflectance and autofluorescence (AF); cross-sectional retinal images were obtained
with optical coherence tomography (OCT). Dark-adapted thresholds were measured in the older patient; and the transient
pupillary light reflex was recorded and quantified in both patients.
Results: Both LCA5 patients had light perception vision only, hyperopia, and nystagmus. P1 showed a prominent central
island of retinal pigment epithelium (RPE) surrounded by alternating elliptical-appearing areas of decreased and increased
pigmentation. Retinal laminar architecture at and near the fovea was abnormal in both patients. Foveal outer nuclear layer
(ONL) was present in P1 and P2 but to different degrees. With increasing eccentricity, there was retinal laminar
disorganization. Regions of pericentral and midperipheral retina in P1, but not P2, could retain measurable ONL and less
laminopathy. P2 had a small central island of perception with >5 log units of sensitivity loss. Pupillary responsiveness
was present in both LCA5 patients; the thresholds were abnormally elevated by ≥5.5 log units.
Conclusions: LCA5 patients had evidence of retained photoreceptors mainly in the central retina. Retinal remodeling was
present in pericentral regions in both patients. The NIR reflectance and NIR-AF imaging in the younger patient suggested
preserved RPE in retinal regions with retained photoreceptors. Detailed phenotype studies in other LCA5 patients with
longitudinal follow-up will help determine the feasibility of future intervention in this rare disease.
Leber  congenital  amaurosis  (LCA)  is  a  molecularly
heterogeneous retinal disease with visual impairment from
early  life  [1,2].  Gene  identification,  proof-of-concept  and
safety  studies  in  animals,  and  detailed  human  studies  of
photoreceptor layer integrity have led to treatment trials in the
molecular form of LCA caused by mutations in RPE65, the
gene encoding retinal pigment epithelium-specific protein,
65 kDa [3-10]. For other molecular forms of LCA, progress
toward human clinical treatment trials is not as far along. One
step that can be taken now, however, is to determine the
treatment potential of the human diseases using detailed study
of  molecularly  clarified  LCA  patients.  To  date,  we  have
conducted studies with this goal in LCA caused by mutations
in CEP290 (Centrosomal protein, 290 kDa), CRB1 (Crumbs
homolog-1),  CRX  (Cone-rod  homeobox-containing  gene),
GUCY2D (Guanylate cyclase 2D, retinal), RDH12 (Retinol
dehydrogenase 12), RPE65,RPGRIP1 (Retinitis pigmentosa
GTPase regulator-interacting protein), or TULP1 (Tubby-like
protein 1) [6,11-19].
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The LCA5 locus was initially mapped to chromosome
6p14.1 [20,21] and more recently the gene was determined to
encode  a  protein,  lebercilin,  involved  with  photoreceptor
ciliary function [22,23]. LCA5 accounts for about 1%–2% of
LCA. An animal model for LCA5 that will permit further
investigations  of  disease  mechanism  is  awaited  [1].  The
literature that identified LCA5 genotypes has included clinical
descriptions of the disease. There is consensus that LCA5
mutations lead to an early and severe visual disturbance with
nystagmus,  abnormal  visual  acuity,  nondetectable
electroretinograms,  and  fundus  features  of  retinal
degeneration  [21,22,24,25].  Further  details  of  retinal
phenotype will be needed to define the potential for any future
therapeutic approach to this rare disorder. We used clinical
evaluation and retinal imaging modalities to study two LCA
patients with the same homozygous LCA5 mutation. Dark-
adapted psychophysics and pupillometry were used to assay
visual function [26,27].
METHODS
Participants:  Two  LCA  patients  with  LCA5  mutations
underwent complete eye examinations and studies of retinal
phenotype.  For  comparison  with  the  LCA5  results,  we
included 30 patients (ages 1–59) who had other forms of LCA
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1098or retinal degenerations not considered LCA. Also studied
were 34 normal participants (ages 5–58). Informed consent
was  obtained  from  all  participants.  The  study  procedures
followed the Declaration of Helsinki and were approved by
the  institutional  review  board  of  the  University  of
Pennsylvania.
En face imaging with scanning laser ophthalmoscope: Near-
infrared (NIR) light was used to perform en face imaging with
a  confocal  scanning  laser  ophthalmoscope  (SLO;  HRA2,
Heidelberg  Engineering  GmbH,  Heidelberg,  Germany)
without subjecting the diseased retina to undue light exposure
[28]. Reflectivity distribution of retinal and subretinal features
was imaged with 820 nm NIR light. Health of the RPE was
estimated with NIR-autofluorescence (NIR-AF) using 790 nm
excitation light and a long-pass blocking filter that allowed
detection of fluorescence emissions of >810 nm [16,28-31].
NIR-AF  signal  is  believed  to  be  dominated  by  the
melanolipofuscin in RPE and melanin in the RPE and choroid
[16,28-36]. Disease-related changes in RPE melanin content
result  in  spatial  variation  of  the  NIR-AF  signal  intensity,
appearance, or both. Imaging was performed in the high-speed
mode; 30°×30° of retina was sampled onto a 768×768 pixel
image, and video segments of up to 10 s length were obtained
at the rate of 8.8 Hz. Detector sensitivity was set to 95% for
NIR-AF. Automatic real-time (ART) averaging feature of the
manufacturer’s software was used whenever possible. When
ART failed, images were exported from the manufacturer’s
software and analyzed as previously described [16,28-31].
Optical coherence tomography: Retinal cross-sections were
obtained with optical coherence tomography (OCT). Data
were acquired in both patients with Fourier-domain (FD) OCT
imaging  (RTVue-100;  Optovue  Inc.,  Fremont,  CA).  The
principles  of  the  method  and  our  recording  and  analysis
techniques  have  been  published  [6,10,14,29,37].  For  this
work, the line protocol of the FD-OCT system, with greater
speed of acquisition, was used to obtain 4.5-mm-long scans
composed of 1,019 longitudinal reflectivity profiles (LRPs)
acquired in approximately 4 ms. Overlapping, nonaveraged,
OCT scans were used to produce a digital montage covering
up to 9 mm eccentricity from the fovea along the horizontal
meridian. A video fundus image was acquired with each OCT
scan.  Regions  of  interest  in  extramacular  retina  were
examined  with  single  horizontal  scans;  the  location  and
orientation  of  the  scan  relative  to  retinal  features  (blood
vessels, RPE depigmentation, and optic nerve head) were
determined by using the digital images of the fundus.
Postacquisition processing of OCT data was performed
with custom programs (MATLAB 6.5, MathWorks, Natick,
MA). LRPs that composed the OCT scans were aligned by
straightening  the  major  RPE  reflection  [6,10,14,37].  Two
nuclear layers, the outer photoreceptor nuclear layer (ONL)
and the inner nuclear layer (INL), were defined in regions of
scans showing two parallel stereotypical hyporeflective layers
sandwiched between the RPE and vitreoretinal interface [6,
14,29]. Inner retinal thickness was defined as the distance
between the signal transition at the vitreoretinal interface and
the sclerad boundary of the INL or the single hyporeflective
layer  continuous  with  the  INL  [6,29,37].  In  normal
participants, the signal corresponding to the RPE was assumed
to be the most sclerad peak within the multi-peaked scattering
signal complex [37], deep in the retina. In abnormal retinas,
the presumed RPE peak was sometimes the only signal peak
deep in the retina; in other cases, it was apposed by other major
peaks. In the latter case, the RPE peak was specified manually
by  considering  the  properties  of  the  backscattering  signal
originating from layers vitread and sclerad to it [38]. Also
assessed were the presence of photoreceptor inner segment
(IS)  and  outer  segment  (OS)  signal  and  outer  limiting
membrane (OLM) signals vitread to the RPE peak [38].
Pupillometry:  The  direct  transient  pupillary  light  reflex
(TPLR) was elicited and recorded as previously published
[10,26,39].  In  brief,  TPLR  luminance-response  functions
were derived from responses to increasing intensities (from
−6.6 to 2.3 log scot-cd.s.m−2) of green stimuli with short
duration (0.1 s) presented monocularly in the dark-adapted
state. The light-stimulated pupil was imaged with an infrared-
sensitive video camera (LCL-903HS; Watec America Corp.,
Las Vegas, NV). Images were digitized by two instruments
simultaneously: a digital image processor (RK-706PCI ver.
114 3.55; Iscan, Inc., Burlington, MA) sampled the horizontal
pupil diameter at 60 Hz; and a video digitizer (PIXCI SV4
board, ver. 2.1; Epix, Inc., Buffalo Grove, IL) produced a
computer file of the video sequence. Records were 5.7 s long,
with a 1 s prestimulus baseline. Artifacts resulting from blinks
were excluded from the analysis. Manual measurement of
digitized  video  images  postacquisition  complemented
automatic measurements performed during the acquisition.
TPLR  response  amplitude  was  defined  as  the  difference
between the pupil diameter at a fixed time (0.9 s) after the
onset of the stimulus and the prestimulus baseline. TPLR
response threshold was defined as the stimulus luminance that
evoked a 0.3 mm criterion (limit of spontaneous oscillations
in pupil diameter), [26] amplitude at 0.9 s.
RESULTS
Two patients were diagnosed clinically with LCA in the first
few months of life. Both patients had nystagmus, limited
visual  responding  from  about  one  month  of  age,  and
nondetectable  electroretinograms.  There  was  no  family
history of similar visual disorders for either patient and there
was no known parental consanguinity. Both patients were of
Ashkenazi  Jewish  ancestry.  Molecular  screening  was
performed in the patients for variations in the AIPL1, CEP290,
CRB1, CRX, GUCY2D, RDH12, RPE65 and RPGRIP1 genes
[2]. There were no plausible disease-causing variations in any
of  these  genes.  Further  studies  revealed  a  homozygous
CAG>TAG nucleotide substitution in the coding sequence of
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Gln279Stop.  This  LCA5  mutation  has  previously  been
reported in one other patient of Ashkenazi Jewish ancestry
[22].
Clinical features and en face infrared fundus images: P1,
at age 6 years, had light perception vision, hyperopia (+6.50
sphere), nystagmus, and no corneal or lenticular opacities. An
en  face  montage  of  the  ocular  fundus  of  P1  using  NIR
reflectance  imaging  showed  a  distinctly  demarcated  dark
central island surrounded by alternating elliptical regions of
lighter and darker appearance (Figure 1A). A schematic of the
darker-appearing regions is shown (Figure 1A, inset left). The
reflectance pattern in LCA5 P1 was in contrast to the more
homogeneous NIR reflectance view from an age-matched
normal subject (Figure 1A, inset right). The lighter regions in
LCA5 P1 showed greater visibility of the choroid, suggesting
depigmentation of RPE. Darker regions likely correspond to
more preserved RPE. NIR-AF provided further information
on the RPE with the use of melanosome-specific signals from
the fundus [31]. High intensity NIR-AF signal originates from
the irregular-shaped central island, suggesting a preserved or
hyperpigmented RPE at this location (Figure 1B). There was
a region of lower intensity NIR-AF in the parafovea, and this
likely corresponds to chorioretinal atrophic change. At greater
eccentricities, there was an incremental increase in NIR-AF.
In the superotemporal and superonasal near midperiphery,
there was a distinct boundary of a further increase in NIR-AF
signal with a spatially homogeneous appearance, representing
more retained and pigmented RPE.
LCA5 patient 2 (P2) was followed from age 6 months
through age 25 years. Visual acuity loss increased from 7/200
(right  eye)  and  20/400  (left  eye)  at  age  6  years  to  light
perception in both eyes at age 25. A high hyperopic refractive
error  was  present  at  all  visits  (+10.00  sphere);  there  was
nystagmus but no corneal or lenticular opacities. Funduscopic
examinations  throughout  the  years  noted  retina-wide
granular-appearing pigmentary disturbances and optic disc
drusen in both eyes, a finding previously noted in LCA5 [1].
An en face montage of the ocular fundus of P2 at age 25, using
NIR reflectance imaging, showed a light appearance with
visibility of the choroid, suggesting depigmentation of RPE
(Figure  1C).  NIR-AF  displayed  a  choroidal-appearing
pattern; specifically there was no evidence of a central region
of  hyperautofluorescence  or  peripheral  boundary  to  a
relatively increased signal (Figure 1D). The optic disc drusen
were evident in the NIR reflectance image (Figure 1C, inset)
and  they  revealed  hyperautofluorescence  under  NIR
excitation (Figure 1D, inset). Optic disc drusen are known to
show AF under short-wavelength excitation [40], but their
NIR-AF signals have not been described.
Between ages 8 and 25 years, P2 was able to perform
kinetic  perimetry  and  showed  only  a  central  island  of
perception in each eye of roughly 2–3 degrees in diameter
(with a large bright target, V-4e). Static threshold perimetry,
Figure 1. En face near-infrared reflectance and autofluorescence
images of the LCA5 patients. A: Near-infrared (NIR) reflectance
(REF) image of the left fundus of P1 is shown. Inset to the left is a
schematic  drawing  of  the  retinal  regions  corresponding  to  low
reflection  (black),  intermediate  reflection  (hatched),  and  high
reflection and choroidal visibility (white). Inset to the right is a NIR
reflectance view of the fundus of a 6 year-old child with normal
vision. B: Near-infrared-autofluorescence (NIR-AF) image of the
left fundus of P1 is shown. Black arrows indicate the boundaries of
the midperipheral transitions to healthier retinal pigment epithelium;
and  gray  arrow  points  to  the  parafoveal  annular  region  of  low
intensity. Inset is a normal image. C: NIR reflectance image of the
left fundus of P2 is shown. Inset is an enlarged view of the optic nerve
head (ONH) region with ONH drusen. D: NIR-AF image of the left
fundus of P2 is shown. Inset is an enlarged view of the ONH region.
All images are shown contrast stretched for visibility of features.
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1100using an achromatic target (size V, but 1 log unit brighter than
the  kinetic  perimeter  4e)  in  the  dark-adapted  state,  was
performed in the left eye of P2. This was initially done when
the patient was 17 years old and then repeated at 25 years of
age. The target was only detected in the central field, and
thresholds were elevated by >5.5 log units at both visits [27].
Cross-sectional  retinal  imaging:  preserved
photoreceptors adjacent to retinal disorganization: Retinal
laminar architecture of LCA5 P1 at age 6 years and P2 at 25
years was examined by high resolution cross-sectional OCT
imaging (Figure 2). The central 14 mm scan of retina along
the horizontal meridian in a normal subject (Figure 2A, upper)
illustrates the foveal depression and the hyporeflective and
hyperreflective  layers  that  have  been  shown  to  have  a
predictable relationship to histologically defined layers [14,
29,37]. Lamination was also present in the patient scans, but
there were abnormalities (Figure 2A, middle and lower). Both
patients had a foveal depression; this was identified as the
deepest pit on raster scanning. P2 had far less depth to the
foveal pit than P1; there was notable epiretinal membrane in
this  scan  and  in  others  (data  not  shown).  Unlike  the
representative normal scan, both patients also showed some
tissue vitread to the foveal ONL. The epifoveal tissue in P1
appeared continuous with parafoveal INL and inner plexiform
and retinal ganglion cell layers. Foveal ONL thickness in P1
measured 43 µm, which is reduced to about 48% of normal
(normal  mean±SD=90±8.6  µm;  n=5;  ages  5–15  years),
suggesting loss of foveal cone cells. Foveal ONL thickness in
P2 measured 101 µm, which is within normal limits. Whether
this hyporeflectivity measured at the fovea in P2 represents
only cone nuclei or is a more complex structure with, for
example, Müller cell hypertrophy is uncertain [38]. Eccentric
to roughly 1.5 mm nasal and temporal to the fovea, the ONL
in both patients is barely discernible. At approximately 7 mm
eccentricity into the temporal retina, normal lamination is no
longer present, and the patient scans have almost a “bilaminar
appearance” with a thick vitread hyperreflective layer and a
deep  thickened  hyporeflective  layer.  The  thick  superficial
layer  likely  includes  inner  plexiform  layer  and  retinal
ganglion cell layer, and the deeper layer may be an amalgam
of thickened INL with remnant photoreceptor nuclei [16,29].
Retinal  thickness  and  especially  inner  retinal  thickness  is
remarkably greater in P2 than in P1.
We determined whether the residual foveal ONL in the
LCA5  patients  was  expected  to  be  associated  with  light
perception vision. In vivo histopathology of the LCA5 patients
was compared to a group of patients with retinal degeneration
and similar foveal ONL thickness, and who had been found,
by  dark-adapted  chromatic  perimetry,  to  be  at  a  stage  of
disease that had reduced vision to a central island with only
abnormal cone function [41] (Figure 2B-D).
The 19 patients with retinal degeneration compared with
LCA5 patients were in the general clinical category of retinitis
pigmentosa (RP) and showed a range of visual acuities from
20/20 to 20/200. These patients were 21 to 59 years of age
with  diagnoses  that  included  X-linked  RP  due  to  RPGR
mutations, Usher syndrome 1B and 2A, and ungenotyped RP.
Their ONL profiles were similar to those of the LCA5 patients
(Figure 2C). This suggested that the foveal cone cells in the
LCA5 patients were not functioning optimally.
Magnified views of the foveal center of P1 and P2 (Figure
2D) demonstrate that the IS/OS signal appears ill-defined in
P1 or nearly not discernible in P2. For comparison are similar
views of the foveal center for a normal subject and for an RP
patient. The RP patient has thinned ONL but more definable
IS/OS signal and better foveal function (visual acuity, 20/40).
This  abnormal  signal  deep  to  the  foveal  cone  ONL  may
indicate structural abnormalities in the cone IS/OS, possibly
a  consequence  of  a  ciliopathy,  with  resultant  visual
dysfunction. At greater eccentricities there was severe ONL
reduction. Remnants of ONL observed in the nasal retina of
P1 were accompanied by a thickened inner retina (Figure 2E,
left  P1  panel)  suggestive  of  retinal  remodeling.  Total
photoreceptor  layer  loss  in  both  patients  resulted  in  a
disorganized retinal structure with a bilaminar appearance
(Figure 2E, right two panels) with a hyper-thick (P1=148 µm;
P2=212 µm) inner retina (normal mean±SD=108±20 µm).
Pupillometric abnormalities in LCA5: TPLR was used to
quantify objectively the pupillometric sensitivity to light in
these two LCA5 patients with limited vision and nondetectable
electroretinograms. For dark-adapted normal eyes, a criterion
response (0.3 mm contraction at 0.9 s) of the TPLR is near
−5.0 log scot-cd.s.m−2 [10,26]. The amplitude of the normal
TPLR  response  grows  as  a  function  of  stimulus  intensity
reaching a saturation value of approximately 2 mm by 2 log
scot-cd.s.m−2.  Both  LCA5  patients  showed  marked
abnormalities in TPLR. Responses for the patients were first
detectable with higher intensity stimuli. P1’s response was
0.22 mm at 0.4 log scot-cd.s.m−2; and P2’s response was
0.55 mm at 1.4 log scot-cd.s.m−2. Contraction amplitude to the
brighter  flash  was  reduced  to  51%  of  normal  mean
(1.91±0.40 mm, n=12) in P1 and to 29% of normal mean in
P2  (Figure  3A).  TPLR  thresholds  derived  from  intensity
response functions were elevated by 5–6 log units in the LCA5
patients (P1=0.51, and P2=1.08 log scot-cd.s.m−2) compared
to normal subjects (mean±2SD=-4.74±0.22 log scot-cd.s.m
−2, n=12).
The TPLR threshold abnormalities in LCA5 were similar
in order of magnitude to those observed in a group of eleven
patients, ages 1–58 years, with different molecular causes of
LCA  and  comparable  levels  of  visual  dysfunction  (visual
acuities of 20/800 or worse). The latter group of LCA patients
had TPLR thresholds with mean±2SD of 0.78±2.40 log scot-
cd.s.m−2 (Figure 3B).
DISCUSSION
Clinical features shared by most of the LCA5 patients reported
to date include the following: severe visual disturbances and
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1101Figure 2. Dysmorphology in the retina of LCA5. A: Cross-sectional OCT images across the horizontal meridian are shown for a normal 6-
year-old subject (upper) and LCA5, P1 (middle) and P2 (lower). Layers or structures are labeled as individual or combined laminae. IPL+RGC,
inner plexiform and retinal ganglion cell layers; INL, inner nuclear layer; ONL, outer nuclear layer; OLM, outer limiting membrane; IS, inner
segments; OS, outer segments; RPE, retinal pigment epithelium. N: Nasal, T: Temporal retina. B: Central scans are shown for a normal subject,
P1, P2, and an RP patient with a residual and abnormally reduced central island of retinal structure. ONL layer is highlighted in blue. C:
Photoreceptor nuclear layer thickness horizontally across the central 4 mm of retina is graphically displayed for a group of normal subjects
(gray represents mean±2SD; n=26; ages 5–58 years), 19 patients with retinal degeneration but not LCA5, and the LCA5 data. For comparison
with LCA5 P1 and P2 with light perception (LP) vision, the ONL data from the patients with retinal degeneration are color-coded by their
visual acuity levels. D: Magnified (1.2 mm across) horizontal cross-sections through the fovea of LCA5 P1 and P2 are compared to those of
the 6-year-old normal subject (left panel) and an RP patient (right panel) with similarly reduced foveal ONL. E: Cross-sectional, 0.9 mm-
long, extramacular images from LCA5 P1 and P2 are compared to a normal subject. Longitudinal reflectivity profiles (LRP, white traces)
overlaid on the scans show signal features corresponding to the different retinal laminae. The ONL is highlighted (blue) next to the
corresponding LRP signal feature. LCA5 P1 (left) at 7 to 7.8 mm in nasal retina shows remnants of ONL, retained retinal lamination and a
thickened inner retina (bracketed to the left of the scans) compared to the normal subject at the same eccentricity. Scans from 7 mm in temporal
retina from both LCA5 patients show complete loss of ONL signal and retinal disorganization with a bilaminar appearance of the LRPs.
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1102nystagmus  from  birth,  hyperopia,  nondetectable
electroretinograms,  and  a  spectrum  of  ophthalmoscopic
findings  from  near  normal  appearance  in  infancy  to
pigmentary retinopathy [20-22,24,25]. Macular atrophy was
noted in older members of an LCA5 family in which younger
members showed minimal change [21]. Maculopathy has also
been observed in early stages of the disease in other LCA5
patients [24]. The studies of photoreceptor and RPE integrity
in the LCA5 patients of this study extend the previous reports.
The  presence  of  a  foveal  depression  with  apparently
retained foveal ONL suggests that central retinal development
occurred  to  some  degree  in  the  LCA5  patients  [42,43].
However, the foveal architecture was not entirely normal:
there were visible laminae vitread to the foveal ONL in P1 and
thickening of the fovea in P2, the latter being previously noted
in choroideremia [38]. The exact basis of these observations
is uncertain but could be due, for example, to incomplete
migration of the inner retina toward the periphery during
foveal development [42,43], epiretinal membrane distortion
of foveal structure, or Müller cell activation, hypertrophy or
proliferation  in  response  to  photoreceptor  cell  death  [38].
Assuming there are retained foveal cone photoreceptors in
LCA5, then the comparison of foveal ONL thickness with
other retinal degenerations at similar severity levels by OCT
structure suggests that LCA5 visual acuity was far worse than
that in the others. This may in part be due to dysfunction from
a ciliopathy with disrupted protein transport between inner
and outer segments [44]. Deep subfoveal retinal structure in
the LCA5 patients, however, was definitely abnormal in the
region conventionally attributed to photoreceptor IS, cilia, and
OS, suggesting a pathological component. Additional study
of the outer retina of LCA5 with ultrahigh resolution OCT
would seem valuable [45,46]. The low visual acuity at a young
age  may  result  from  cone  photoreceptor  ciliopathy  but  a
component of refractive amblyopia also cannot be ruled out.
A diminished photoreceptor layer was detected at extra-
central locations, but regions of no detectable ONL were also
present. This indicates that even as early as age 6 years, there
is  considerable  photoreceptor  loss.  Between  loci  with
detectable  ONL  were  regions  that  had  disorganized
lamination. The hallmarks of retinal remodeling were present
in these regions: thickened inner retinal layers including inner
plexiform and nuclear layers, and reduced to imperceptible
outer plexiform and outer nuclear layers [16,29,38,47]. We
previously compared such OCT findings in human CEP290-
LCA  and  adRP  due  to  rhodopsin  mutations  with
histopathology of relevant murine models (rd16 mouse and
T17M  rhodopsin  mutant  mouse)  and  the  results  of  these
studies support the notion of delaminated remodeled retina in
the LCA5 patients [16,29].
The pattern of pigment preservation and loss, as revealed
by NIR reflectance and AF in P1, is worthy of comment. If
pigmentary  losses  are  assumed  to  be  a  sequela  of
photoreceptor losses, as in many other retinal degenerations
[29,48], we speculate that the preserved pigment could be a
useful surrogate for photoreceptor preservation. The patterns
of  alternating  elliptical-appearing  areas  of  decreased  and
increased pigmentation are reminiscent of topographical maps
of human photoreceptor density [49]. The preserved central
photoreceptors and pigment may be simply due to the high
density  of  cones  in  this  region;  the  ellipse  of  increased
pigmentation near the vessel arcades may represent relative
preservation of pigment and photoreceptors due to the higher
density of rod photoreceptors in that region. The decreased
pigment between these two regions may be due to the drop of
receptor density (combined rod and cone) between foveal
cone density peak and rod density peak. A more peripheral
ring of increased cone density has been documented and may
relate to the increased pigment noted in the LCA5 patient
[49].
In the current work, the TPLR proved to be a helpful
adjunct measure of vision in these LCA5 patients with severe
visual loss. Pupils responded to short-duration, bright light
stimuli, optimized to elicit a pupillary reflex mediated by
conventional  photoreceptors  [26]  although  a  contribution
from  intrinsically  light-sensitive  ganglion  cells  cannot  be
ruled out [50]. The TPLR was abnormal in the patients, as has
been described in other groups of LCA patients [10,26,39].
Figure 3. Transient pupillary light reflex (TPLR) abnormalities in
LCA5 patients. A: Change in pupil diameter is plotted as a function
of time in response to short duration (0.1 s) light stimuli of two
different intensities (0.4 and 1.4 log scot-cd.s.m−2; denoted at right
end of traces) in the LCA5 patients (filled symbols). A response
elicited with the brighter stimulus in a 9-year-old normal subject is
shown  for  comparison  (unfilled  symbols).  Stimulus  monitor  is
shown at lower left of each of the two panels. B: TPLR response
thresholds to a 0.3 mm criterion response in the LCA5 patients (filled
symbols) are compared to a group of 11 LCA patients, age 1–58
years,  with  severely  impaired  vision  (unfilled  symbols).  TPLR
response amplitudes are measured at a fixed time of 0.9s (vertical
dashed line in A). Thresholds in the LCA5 patients and other LCA
patients show elevations in excess of 5 log units from normal. Gray
hexagon denotes normal mean±2SD.
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1103Thresholds were extremely elevated as in other LCA patients
with comparable degrees of visual loss.
Once  animal  models  of  LCA5  are  established  and
investigated,  it  will  be  of  strong  interest  to  decide  how
faithfully they will relate to the noninvasive retinal structural
and functional findings in LCA5 patients. The major rod loss
at an early age, evident already in the 6-year-old LCA5 patient
of  this  study,  should  be  considered  even  at  the  proof-of-
concept stage of study in models of LCA5. It may be of value
eventually  to  direct  therapy  at  cones,  whether  by  gene
replacement or other methods. Our studies of the CEP290
form of LCA, another ciliopathy with mainly a residual central
island of cones and RPE, led to a similar recommendation
[16].
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